Abstract
Chronic kidney disease (CKD) leads to significant bone loss primarily through the development of cortical porosity. In both patients and animal models of CKD, sustained elevations in serum parathyroid hormone (PTH) are associated with cortical porosity. In this study, we aimed to track the progression of cortical porosity and increased PTH utilizing the adenine-induced CKD model. Young female mice (8 weeks) were given 0.2% adenine to induce CKD. Tissues were collected from groups of adenine and age-matched control mice after 2, 6, and 10 weeks. Serum blood urea nitrogen was elevated at all time points in adenine mice, but serum PTH was only statistically elevated at the 10-week time point. Cortical porosity was sevenfold higher in 6-week adenine mice compared to age-matched controls and 14-fold higher in 10-week adenine mice vs. controls. Additionally, osteocyte receptor activator of nuclear factor κB ligand (RANKL) was elevated in adenine-fed mice, while annexin V, an early marker of cellular apoptosis, was mildly decreased in osteocytes in adenine-fed mice. Based on these results, we hypothesize high serum PTH signals to osteocytes prolonging their lifespan resulting in sustained RANKL which drives osteoclastic bone resorption in the cortex. In conclusion, our data show time-dependent elevations in serum PTH and cortical porosity in adenine-induced CKD mice and demonstrate changes in osteocyte RANKL and apoptosis which may contribute to the development of cortical pores.
Similar content being viewed by others
References
Alem AM, Sherrard DJ, Gillen DL et al (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396–399. https://doi.org/10.1046/j.1523-1755.2000.00178.x
Maravic M, Ostertag A, Torres PU, Cohen-Solal M (2014) Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int 25:159–165. https://doi.org/10.1007/s00198-013-2435-1
Nickolas TL, Stein EM, Dworakowski E et al (2013) Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res 28:1811–1820. https://doi.org/10.1002/jbmr.1916
Pimentel A, Ureña-Torres P, Zillikens MC et al (2017) Fractures in patients with CKD—diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92:1343–1355. https://doi.org/10.1016/j.kint.2017.07.021
Jadoul M, Albert JM, Akiba T et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70:1358–1366. https://doi.org/10.1038/sj.ki.5001754
Bellido T, Saini V, Pajevic PD (2013) Effects of PTH on osteocyte function. Bone 54:250–257. https://doi.org/10.1016/j.bone.2012.09.016
Wein MN (2018) Parathyroid hormone signaling in osteocytes. JBMR Plus 2:22–30. https://doi.org/10.1002/jbm4.10021
Jilka RL, Weinstein RS, Bellido T et al (1999) Increased bone formation byprevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439–446. https://doi.org/10.1172/JCI6610
Weinstein RS, Jilka RL, Almeida M et al (2010) Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151:2641–2648. https://doi.org/10.1210/en.2009-1488
Jilka RL, O’Brien CA, Roberson PK et al (2014) Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. J Bone Miner Res 29:103–117. https://doi.org/10.1002/jbmr.2007
Moe SM, Chen NX, Newman CL et al (2014) A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res 29:902–910. https://doi.org/10.1002/jbmr.2089
Moe SM, Chen NX, Newman CL et al (2015) Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30:539–549. https://doi.org/10.1002/jbmr.2372
Mcnerny EMB, Buening DT, Aref MW et al (2019) Time course of rapid bone loss and cortical porosity formation observed by longitudinal μ CT in a rat model of CKD. Bone 125:16–24. https://doi.org/10.1016/j.bone.2019.05.002
Claramunt D, Gil-Peña H, Fuente R et al (2015) Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia. Am J Physiol 309:F57–F62. https://doi.org/10.1152/ajprenal.00051.2015
Henley C, Davis J, Miller G et al (2009) The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol 616:306–313. https://doi.org/10.1016/j.ejphar.2009.05.013
Tamagaki K, Yuan Q, Ohkawa H et al (2006) Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 21:651–659. https://doi.org/10.1093/ndt/gfi273
Santana AC, Degaspari S, Catanozi S et al (2013) Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. Nephrol Dial Transplant 28:1140–1149. https://doi.org/10.1093/ndt/gfs569
Jia T, Olauson H, Lindberg K et al (2013) A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol 14:116
Katsumata K, Kusano K, Hirata M et al (2003) Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64:441–450. https://doi.org/10.1046/j.1523-1755.2003.00126.x
Clinkenbeard EL, Allen MR, Kenneth E et al (2019) Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD. JCI Insight 4:e123817
Metzger CE, Narayanan SA, Zawieja DC, Bloomfield SA (2019) A moderately elevated soy protein diet mitigates inflammatory changes in gut and in bone turnover during chronic TNBS-induced inflammatory bowel disease. Appl Physiol Nutr Metab 44:595–605. https://doi.org/10.1139/apnm-2018-0514
Narayanan SA, Metzger CE, Bloomfield SA, Zawieja DC (2018) Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J 32:4848–4861. https://doi.org/10.1096/fj.201800178R
Neven E, Dauwe S, De Broe ME et al (2007) Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 72:574–581. https://doi.org/10.1038/sj.ki.5002353
Stockelman MG, Lorenz JN, Smith FN et al (2012) Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency mouse pregnancy. Am J Physiol 275(1):F154–F163
Neven E, Dams G, Postnov A et al (2009) Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant 24:1790–1799. https://doi.org/10.1093/ndt/gfn737
Ferrari GO, Ferreira JC, Cavallari RT et al (2014) Mineral bone disorder in chronic kidney disease: Head-to-head comparison of the 5/6 nephrectomy and adenine models. BMC Nephrol 15:1–7. https://doi.org/10.1186/1471-2369-15-69
Wesseling-Perry K, Jüppner H (2013) The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications. Bone 54:222–229. https://doi.org/10.1016/j.bone.2012.10.008
Graciolli FG, Neves KR, Barreto F et al (2017) The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease. Kidney Int 91:1436–1446. https://doi.org/10.1016/j.kint.2016.12.029
Bonucci E, Gherardi G (1977) Osteocyte ultrastructure in renal osteodystrophy. Virchows Arch A 373:213–231. https://doi.org/10.1007/BF00432238
Heveran CM, Schurman CA, Acevedo C et al (2019) Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice. Bone 127:91–103. https://doi.org/10.1016/j.bone.2019.04.019
Nakashima T, Hayashi M, Fukunaga T et al (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231–1234. https://doi.org/10.1038/nm.2452
Xiong J, Onal M, Jilka RL et al (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17:1235–1241. https://doi.org/10.1038/nm.2448
Sabbagh Y, Graciolli FG, O’Brien S et al (2012) Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27:1757–1772. https://doi.org/10.1002/jbmr.1630
Pereira RC, Salusky IB, Roschger P et al (2018) Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy. Kidney Int 94:1002–1012. https://doi.org/10.1016/j.kint.2018.08.011
Plotkin LI (2014) Apoptotic osteocytes and the control of targeted bone resorption. Curr Osteoporos Rep 12:121–126. https://doi.org/10.1007/s11914-014-0194-3
Manolagas SC, Parfitt AM (2014) For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone 54:272–278. https://doi.org/10.1016/j.bone.2012.09.017.FOR
Tani T, Orimo H, Shimizu A, Tsuruoka S (2017) Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease. Sci Rep 7:1–12. https://doi.org/10.1038/s41598-017-02351-6
Tamura M, Aizawa R, Hori M, Ozaki H (2009) Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem Cell Biol 131:483–490. https://doi.org/10.1007/s00418-009-0557-5
Ogirima T, Tano K, Kanehara M et al (2006) Sex difference of adenine effects in rats: renal function, bone mineral density and sex steroidogenesis. Endocr J 53:407–413
Acknowledgements
This work was supported by VA Merit Award (BX003025) from the United States (US Department of Veterans Affairs [Biomedical Laboratory Research and Development Service]) and the NIH (F32DK122731).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
CEM, EAS, and MRA have no conflicts of interest to disclose.
Human and Animal Rights and Informed Consent
All animal procedures were approved by the Indiana University School of Medicine Animal Use and Care Committee prior to any experiments being initiated.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Metzger, C.E., Swallow, E.A. & Allen, M.R. Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD. Calcif Tissue Int 106, 392–400 (2020). https://doi.org/10.1007/s00223-019-00642-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-019-00642-w